日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Nation
Pharma firms start work on H1N1 vaccine
2009-Jul-7 11:03:08

China has announced that it would stockpile the H1N1 flu vaccine for 1 percent of the population by Oct 1, even as the 10 designated Chinese vaccine producers are getting busy with development and clinical trials.

The stockpile of 13 million injections will be used as a preventive measure to counter any sudden outbreak of the flu, Liang Wannian, deputy director of the Ministry of Health's contingency office, said.

He said the flu vaccine would be chiefly targeted at high-risk groups -- people with prevalent illnesses and pregnant women.

The first batch of China's H1N1 flu vaccine, developed by these 10 companies, is expected to be ready by the end of the month, and would undergo a two-month clinical trial before it is made available to the public, he said.

The 10 local vaccine makers include Beijing Sinovac Biotech Co Ltd, Zhuhai Hualan Biological Engineering Inc and Shenzhen Neptunus Interlong Bio-tech Co Ltd.

Sinovac announced recently that it had completed construction of the H1N1 virus seed bank necessary to produce a virus antigen.

The company received the seed virus from the US Center for Disease Control on June 8 and started producing the H1N1 vaccine the same day.

Sinovac said it expected to complete production of the first batch and initiate clinical trials of the vaccine by the end of this month. The flu vaccine has been named PANFLU.

The company got 100 million yuan on June 29 as loan from the Bank of Beijing, which will be used to purchase pharmaceutical raw material and for expanding its manufacturing facility, according to Sinovac Chairman, President and CEO Yin Weidong. The company's current annual vaccine production capacity is between 20 million and 30 million doses.

Shenzhen-listed Hualan Biological Engineering Inc said on July 1 that its equity holding subsidiary Hualan Biological Vaccine Co Ltd, a H1N1 vaccine developer, had borrowed 20 million yuan from each of the two shareholders of the parent company to fund its vaccine development effort.

Hualan can now manufacture nearly 200 million doses annually.

Li Yingpeng, a pharmaceutical analyst at Galaxy Securities, said 13 million doses of the H1N1 vaccine implied the vaccine makers could net a business of over 300 million yuan, as the average market price of other vaccines in China was around 30 yuan per dose.

"Though it seems these 10 companies have grabbed the huge business opportunities, they are, at the same time, shouldering high risks," Li said.

He said since the evolution of the H1N1 flu could not be predicted accurately, the returns on the huge investment required for development of the vaccine and clinical trials could not be guaranteed.

[Jump to ]
Nation | Biz | Comment | World | Celebrity | Odds | Sports | Travel | Health
ChinaDaily Mobile News
m.chinadaily.com.cn
To subscribe to China Daily, call 010-64918763 or email to circu@chinadaily.com.cn
主站蜘蛛池模板: 97超碰人人干 | 亚洲视频色 | 欧洲一区二区在线 | 国产视频一区二区在线播放 | 国产无遮挡免费视频 | 亚洲天堂tv | 91丨九色丨丰满人妖 | 五月激情六月 | 在线观看免费黄色 | 国产一区成人 | av成人在线看| 手机免费观看av | 51精产品一区一区三区 | 99爱在线视频 | 豪放女大兵在线观看 | 欧美精品一 | 自拍 亚洲| 成年人视频免费在线观看 | 成人精品一区二区三区中文字幕 | 在线超碰av | 中文一区在线观看 | 国产中出 | 华人永久免费 | 伊人久久精品一区二区三区 | 亚洲天堂男人天堂 | 特黄aaaaaaaaa真人毛片 | 中国一级特黄毛片 | 成人黄色在线免费观看 | 香蕉视频在线免费看 | 国产精品国产三级国产普通话蜜臀 | 69精品久久久久久 | 韩国一级黄色片 | 超碰在线最新 | 成年人晚上看的视频 | 网站黄在线 | 91极品视频| 国产一区二区在线视频 | 日韩一级免费毛片 | 亚洲午夜伦理 | 欧美日韩精选 | 青青av在线 |